The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker selection for patients participating in phase I clinical trials.
 
Lauriane Eberst
No Relationships to Disclose
 
Clemence Basse
No Relationships to Disclose
 
Magali Morelle
No Relationships to Disclose
 
Victor Simmet
No Relationships to Disclose
 
Catherine Terret
No Relationships to Disclose
 
Daniel Pissaloux
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Qing Wang
No Relationships to Disclose
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; Pfizer; Roche
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Novartis; Roche